Article ID Journal Published Year Pages File Type
6241276 Respiratory Medicine 2016 31 Pages PDF
Abstract
Aclidinium 400 μg/formoterol 12 μg was well tolerated, with a safety profile similar to formoterol 12 μg and consistent with that seen in two Phase III studies. Additionally, aclidinium 400 μg/formoterol 12 μg improved lung function versus formoterol 12 μg, with a sustained effect over one year.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Preview
Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD
Authors
, , , , ,